Last reviewed · How we verify

NCT06928350

Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants

Recruiting now Last updated 11 June 2025
What this trial tests

trial in GERD (Gastroesophageal Reflux Disease) in 50 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
1 May 2026
1 May 2026

Quick facts

Lead sponsorAsian Institute of Gastroenterology, India
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 April 2025
Primary completion1 May 2026
Estimated completion1 May 2026
Sites1 location across India

Conditions studied

Sponsor

Asian Institute of Gastroenterology, India

Who can join

Adults 18 to 50, any sex, with GERD (Gastroesophageal Reflux Disease). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine normal 24-hour pH-impedance monitoring values, including acid exposure time (AET), in healthy Indian adults. It will help improve GERD diagnosis in India by providing population-specific data. The study will also explore how diet, body position, and nighttime reflux affect acid exposure. Healthy volunteers aged 18 and above will be monitored for 24 hours.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for GERD (Gastroesophageal Reflux Disease)

Currently open trials in the same condition.

Other Asian Institute of Gastroenterology, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06928350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing